Seegene and Hologic Form Worldwide Collaboration to Develop High Multiplex Molecular Diagnostic Assays
Published on: PR Newswire GenomeWeb Seoul, Korea, November 4, 2016 — Seegene Inc. (096530.KQ) today announced it has entered into a worldwide collaboration agreement with Hologic (Nasdaq:
Seegene to Introduce Automated Development of in silico-based Multiplex Real-time PCR Assays
Published on: PR Newswire Pressemitteilung lavanguardia 共同通信PRワイヤー (プレスリリース) HiNet 新聞社群 中华网 ThaiPR.net (ข่าวประชาสัมพันธ์) LeLézard.com foodqualitynews Customized assay design that dramatically reduces development time and cost Looking for potential local strategic partners in molecular
Seegene to Introduce Novel Real-Time PCR Technology at ASM Microbe 2016
Published on: PR Newswire Jun 08, 2016 – Introducing a new SG oligo system which significantly saves assay development time and cost– Driving standardization of
Seegene Technologies to Unleash Customized Multiplex PCR Solutions and Support for U.S. Market
Published on: BUSINESS WIRE Mar 07, 2016 Newly established innovation division at Seegene Technologies will deliver customized assays of increased complexity while maintaining sensitivity, specificity,
Seegene and BD Form Worldwide Collaboration to Develop Multiplex Molecular Diagnostic Assays
Published on GenomeWeb MarketWatch RTT News Seegene and BD Form Worldwide Collaboration to Develop Multiplex Molecular Diagnostic Assays Seoul, Korea, and Baltimore, MD, September 14, 2015 —
Seegene and QIAGEN Enter into a Collaboration to Develop Multiplex Molecular Diagnostic Assay
Published on: GenomeWeb Nasdaq streetinsider Seoul, Korea, and Hilden, Germany, July 8, 2015 — Seegene Inc. (096530.KQ), today announced that it has entered into aworldwide collaboration agreement with QIAGEN